Certified by Founder Lodge
Cargene Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $19,200,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 2020, Cargene Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver fibrosis and ophthalmic disorders, with operat
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 14 ,2021 | Pre Series A | $19,200,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Mangusta Capital | $25,000,000 | (Nov 20, 2025)
Bedrock Data | $25,000,000 | (Nov 20, 2025)
Synthio Labs | $5,000,000 | (Nov 20, 2025)
Manta Cares | $5,400,000 | (Nov 20, 2025)
Method Security | $26,000,000 | (Nov 20, 2025)
